Popular Science on Lung Cancer in the Age of Immunity: How long can lung cancer patients live in the era of tumor immunotherapy?

Special thanks to this video

Li Wei

Deputy Chief Physician, Department of Oncology, Shanghai Pulmonary Hospital, Tongji University

Column Introduction

Health is the foundation and necessary condition for human development; with the development of the economy, people's demand for health is becoming increasingly urgent. In October 2016, the State Council issued the "Healthy China 2030" Planning Outline. In May 2020, the Third Session of the 13th National People's Congress pointed out that popular science propaganda and health education are the "social vaccines" for disease prevention and control, and health knowledge should be vigorously popularized. "Go all out to love and have a doctor to say one" - the National Tumor Knowledge Popular Science Project is a popular science brand column for tumor prevention and treatment that came into being at the call of the National Health Commission. It aims to allow more medical science workers to participate in activities that care for people's health, create more popular science works, convey popular science knowledge of standardized treatment, and solve patients' confusion in treatment. Do warm popular science and let more patients feel the dedication and warmth of medical science workers.

With the rapid development of immunotherapy, the large amount of and rapidly updated treatment and medication information often makes patients more confused. The "Doctors Say - Popular Science in the Immune Era" column invites authoritative experts to systematically explain standardized immunotherapy knowledge around immunotherapy, step by step, to spread the doctors' voices, new technologies, new methods, and new standards of clinical diagnosis and treatment to more patient groups, so that everyone can better understand the popular science knowledge about the disease and get a healthier life.